Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
3,285
Showing 50 of 3,285
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 151 | BYND | Beyond Meat, Inc. | 15/18 | 5 | 93% | +39.6% | +49.8% | +75.7% | -40.9% |
| 152 | ASPN | Aspen Aerogels Inc | 28 | 12 | 79% | +39.4% | +47.4% | +205.7% | -149.6% |
| 153 | FNGR | Fingermotion, Inc. | 38/45 | 3 | 87% | +39.4% | +35.9% | +233.7% | -115.3% |
| 154 | LWLG | Lightwave Logic, Inc. | 38/50 | 9 | 89% | +39.3% | +54.7% | +60.4% | -62.4% |
| 155 | GANX | Gain Therapeutics, Inc. | 13 | 6 | 85% | +39.2% | +15.6% | +148.7% | -57.0% |
| 156 | SMC | Summit Midstream Corp | 135/141 | 8 | 100% | +39.2% | +39.4% | +56.0% | +17.4% |
| 157 | VXRT | Vaxart, Inc. | 14/15 | 5 | 79% | +39.0% | +61.3% | +78.4% | -73.5% |
| 158 | BSLK | Bolt Projects Holdings, Inc. | 24 | 6 | 75% | +38.7% | +63.3% | +97.9% | -96.8% |
| 159 | TISI | Team Inc | 133/145 | 12 | 53% | +38.7% | +5.5% | +196.4% | -52.4% |
| 160 | BENF | Beneficient | 74 | 4 | 85% | +38.7% | +58.5% | +84.6% | -88.5% |
| 161 | PTLO | Portillo'S Inc. | 55/57 | 18 | 76% | +38.5% | +64.1% | +64.1% | -47.7% |
| 162 | ZNTL | Zentalis Pharmaceuticals, Inc. | 145/159 | 23 | 88% | +38.5% | +48.7% | +73.7% | -51.3% |
| 163 | RVLV | Revolve Group, Inc. | 217/271 | 4 | 100% | +38.4% | +38.8% | +57.7% | +11.1% |
| 164 | CLVR | Clever Leaves Holdings Inc. | 25 | 7 | 84% | +38.0% | +51.8% | +100.0% | -49.3% |
| 165 | AMPG | Amplitech Group, Inc. | 21/25 | 5 | 48% | +37.7% | -8.9% | +266.4% | -29.6% |
| 166 | NNBR | Nn Inc | 207/278 | 24 | 71% | +37.6% | +56.1% | +102.0% | -36.0% |
| 167 | PLUG | Plug Power Inc | 10/13 | 4 | 70% | +37.3% | +22.8% | +254.5% | -56.5% |
| 168 | CHGG | Chegg, Inc | 13/14 | 5 | 85% | +37.3% | +38.3% | +66.6% | -8.3% |
| 169 | SMSI | Smith Micro Software, Inc. | 10/12 | 3 | 70% | +37.3% | +62.7% | +79.4% | -29.7% |
| 170 | LYRA | Lyra Therapeutics, Inc. | 112/114 | 16 | 70% | +37.3% | +30.0% | +85.1% | -87.0% |
| 171 | ORMP | Oramed Pharmaceuticals Inc. | 11 | 6 | 91% | +37.2% | +45.5% | +77.6% | -45.5% |
| 172 | SLNG | Stabilis Solutions, Inc. | 22/25 | 7 | 91% | +37.1% | +26.9% | +89.2% | -25.6% |
| 173 | OM | Outset Medical, Inc. | 198/213 | 10 | 81% | +37.0% | +39.0% | +84.9% | -66.7% |
| 174 | EHTH | Ehealth, Inc. | 15/17 | 7 | 53% | +37.0% | +14.6% | +162.2% | -48.8% |
| 175 | ATER | Aterian, Inc. | 39 | 11 | 97% | +36.8% | +36.5% | +64.4% | -45.6% |
| 176 | HBB | Hamilton Beach Brands Holding Co | 12 | 3 | 100% | +36.5% | +30.7% | +78.5% | +3.3% |
| 177 | FTCI | Ftc Solar, Inc. | 190/199 | 19 | 81% | +36.4% | +37.3% | +158.2% | -158.2% |
| 178 | BRBR | Bellring Brands, Inc. | 49/51 | 9 | 86% | +36.3% | +48.6% | +73.0% | -52.2% |
| 179 | ASPI | Asp Isotopes Inc. | 45/56 | 9 | 76% | +36.3% | +40.5% | +359.2% | -151.4% |
| 180 | CHPT | Chargepoint Holdings, Inc. | 347/356 | 27 | 99% | +35.8% | +29.3% | +79.4% | -66.9% |
| 181 | KROS | Keros Therapeutics, Inc. | 129/136 | 24 | 95% | +35.8% | +33.8% | +76.5% | -90.2% |
| 182 | TACT | Transact Technologies Inc | 60/62 | 12 | 85% | +35.8% | +49.9% | +65.7% | -50.0% |
| 183 | CMPR | Cimpress PLC | 87/96 | 8 | 87% | +35.6% | +47.1% | +94.0% | -39.0% |
| 184 | ORGO | Organogenesis Holdings Inc. | 152/155 | 19 | 88% | +35.5% | +49.0% | +117.3% | -50.8% |
| 185 | OSS | One Stop Systems, Inc. | 12/15 | 7 | 92% | +35.4% | +22.7% | +131.1% | -21.5% |
| 186 | MLSS | Milestone Scientific Inc. | 82 | 6 | 87% | +35.3% | +39.4% | +68.4% | -34.8% |
| 187 | KITT | Nauticus Robotics, Inc. | 23/24 | 8 | 78% | +35.3% | +67.3% | +84.9% | -84.8% |
| 188 | KYMR | Kymera Therapeutics, Inc. | 568/686 | 34 | 54% | +35.2% | +32.9% | +178.3% | -119.8% |
| 189 | AVBH | Avidbank Holdings, Inc. | 21/41 | 21 | 100% | +35.1% | +36.7% | +36.7% | +31.2% |
| 190 | UPLD | Upland Software, Inc. | 11 | 4 | 64% | +35.1% | +33.3% | +109.5% | -18.7% |
| 191 | TTGT | Techtarget Inc | 19 | 6 | 100% | +34.8% | +44.3% | +46.8% | +7.5% |
| 192 | LION | Lionsgate Studios Corp. | 56/59 | 10 | 100% | +34.8% | +43.0% | +59.4% | +6.1% |
| 193 | ARX | Accelerant Holdings | 18/20 | 11 | 89% | +34.8% | +50.6% | +50.6% | -50.6% |
| 194 | CRDF | Cardiff Oncology, Inc. | 10 | 3 | 70% | +34.7% | +11.2% | +220.0% | -27.9% |
| 195 | IMRX | Immuneering Corp | 91/96 | 17 | 89% | +34.6% | +11.7% | +217.6% | -30.3% |
| 196 | WYNN | Wynn Resorts Ltd | 55 | 13 | 91% | +34.6% | +28.1% | +88.4% | -40.5% |
| 197 | INTT | Intest Corp | 15/18 | 4 | 93% | +34.5% | +36.4% | +137.3% | -23.2% |
| 198 | ZURA | Zura Bio Ltd | 10/14 | 10 | 80% | +34.5% | +45.9% | +70.4% | -27.6% |
| 199 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 119/130 | 11 | 76% | +34.4% | +38.1% | +122.6% | -69.1% |
| 200 | ULBI | Ultralife Corp | 58/71 | 5 | 64% | +34.3% | +20.6% | +154.5% | -33.9% |